| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |